SCHEDULE

Day 1 – Clinical Aspects of Breast Density

6:00 AM
7:00 AM

Registration & Breakfast

7:00 AM
7:15 AM

Welcome

Opening Oli Chant
Kalani Brady | Native Hawaiian Health, JABSOM, University of Hawaiʻi

Introduction
Co-Director John Shepherd, PhD | UH Cancer Center

7:15 AM
9:15 AM

Clinical Aspects I

Moderator: Steve Cummings
7:15 AM
Clinical Aspects Talk 1

Risk-Based Screening: When to Start and When to Use Supplemental Imaging Based on Breast Density and Risk
Diana Miglioretti, PhD | Department of Public Health Sciences, University of California, Davis

7:55 AM
Clinical Aspects Talk 2

MRI screening and interval cancers (DENSE)
Carla van Gils, PhD | Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht

8:35 AM
Clinical Aspects Talk 3

Breast cancer risk models that combine a polygenic risk score, mammographic density and endogenous hormones
Susan Hankinson, ScD | School of Public Health and Health Sciences, University of Massachusetts

9:15 AM
9:45 AM

Coffee Break

9:45 AM
11:45 AM

Clinical Aspects II

Moderator: Gertraud Maskarinec
9:45 AM
Clinical Aspects Talk 4

The Measurement Challenge – International case-control study of mammographic measures that predict breast cancer risk
Jennifer Stone, PhD | Centre for Genetic Origins of Health and Disease, University of Western Australia

10:25 AM
Clinical Aspects Talk 5

Factors that change breast density and impact breast cancer risk
Per Hall, MD, PhD | Karolinska Institute

11:05 AM
Clinical Aspects Talk 6

Dense Breast Legislation: What does it mean for patients and providers?
Christine Gunn, PhD | Women’s Health Unit, General Internal Medicine, Boston University School of Medicine

11:45 AM
12:45 PM

Lunch

Hula Performance
Wahine Hula Akala

12:45 PM
1:25 PM

Clinical Aspects II (cont.)

Moderator: Gertraud Maskarinec
12:45 PM
Clinical Aspects Talk 7

Breast MRI Background Parenchymal Enhancement: Emerging Risk and Response Imaging Biomarker
Vignesh Arasu, MD, PhD | Kaiser Permanente Vallejo Medical Center

1:25 PM
2:00 PM

Break

2:00 PM
7:30 PM

Afternoon Networking Activities

UH Cancer Center Tours
2:30 PM, 3:30 PM / van or walk

Magic Island Picnic Networking Reception
4:00 PM – 7:30 PM / van or walk

Day 2 – Breast Density Workshop

7:00 AM
8:00 AM

Registration & Breakfast
Breakout Discussion

8:00 AM
8:15 AM

Housekeeping

8:15 AM
9:35 AM

Biology and Characteristics

Moderator: Per Hall
8:15 AM
Plenary Talk 1

Morphometric features of benign breast tissue: Implications for breast cancer risk
Lynn Chollet-Hinton, PhD | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

8:55 AM
Poster Talk 1

Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing diagnostic image-guided breast biopsy
Clara Bodelon, PhD | National Cancer Institute

9:15 AM
Poster Talk 2

Opportunities and Challenges for the Identification of Histological Correlates of Mammographic Density in Patients with Benign Breast Disease
Maeve Mullooly, PhD | Royal College of Surgeons in Ireland

9:35 AM
10:05 AM

Coffee Break

10:05 AM
11:25 AM

Biology and Characteristics (cont.)

Moderator: Per Hall
10:05 AM
Plenary Talk 2

Breast density research in diverse populations and health disparities
Parisa Tehranifar, DrPH | Mailman School of Public Health, Columbia University Medical Center

10:45 AM
Plenary Talk 3

Mammographic breast density and cancer risk in Asian women
Soo-Hwang Teo, MD | Breast Cancer Research Programme, Cancer Research Malaysia

11:25 AM
12:25 PM

Lunch

12:25 PM
1:10 PM

Poster Session 1 – Even-Numbered

1:10 PM
2:10 PM

Methods

Moderator: John Shepherd
1:10 PM
Plenary Talk 4

A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction
Regina Barzilay, PhD | Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology

1:50 PM
Poster Talk 3

Portable spectroscopic device an alternative method to measure Breast Density at young ages and large population studies. Pilot Study.
Ana Pereira, PhD | Institute of Nutrition and Food Technology, University of Chile

2:10 PM
2:40 PM

Coffee Break

2:40 PM
4:00 PM

Methods (cont.)

Moderator: John Shepherd
2:40 PM
Plenary Talk 5

Machine Learning and Texture Features
Sue Astley, PhD | Division of Informatics, Imaging and Data Science, Faculty of Medicine, Biology and Health, University of Manchester

3:20 PM
Poster Talk 4

New mammography-based measures of breast cancer risk
John Hopper, PhD, NHMRC Senior Principal Research Fellow | School of Population and Global Health, University of Melbourne

3:40 PM
Poster Talk 5

AI-based quantitative breast density assessment using transmission ultrasound
Bilal Malik, PhD | QT Ultrasound Labs

4:00 PM
4:30 PM

Break

4:30 PM
8:00 PM

Diamond Head Luau Networking Event

Day 3 – Breast Cancer Risk Assessment

7:00 AM
8:00 AM

Registration & Breakfast
Breakout Discussion

8:00 AM
8:15 AM

Housekeeping

8:15 AM
9:35 AM

Risks Assessment I

Moderator: Karla Kerlikowske
8:15 AM
Plenary Talk 6

Obesity and Breast Cancer Risk: The Multiethnic Story of Hawaii
Gertraud Maskarinec, MD, PhD | University of Hawaiʻi Cancer Center

8:55 AM
Poster Talk 6

A Clinical Model for Assessing the Individual Breast Cancer Risk in Mammography Screening
Mikael Eriksson, PhD | Department of Medical Epidemiology and Biostatistics, Karolinska Institute

9:15 AM
Poster Talk 7

Birth cohort effect on breast density of Dutch women
George Napolitano | Department of Public Health, University of Copenhagen

9:35 AM
10:05 AM

Coffee Break

10:05 AM
11:25 AM

Risks Assessments I (cont.)

Moderator: Karla Kerlikowske
10:05 AM
Plenary Talk 7

Digital breast tomosynthesis mammography and cancer detection – the To-Be trial
Solveig Hofvind, PhD | Cancer Registry of Norway, Oslo Metropolitan University

10:45 AM
Poster Talk 8

Impact of Breast Density Legislation on Ultrasound Use, 2002-2016
Katherine Callaway, PhD | Harvard Medical School/Harvard Pilgrim Healthcare Institute

11:25 AM
12:25 PM

Lunch

12:25 PM
1:25 PM

Poster Session 2 – Odd-Numbered

1:25 PM
2:25 PM

Risks Assessments II

Moderator: Nico Karssemeijer
1:25 PM
Plenary Talk 8

Women Informed to Screen Depending On Measured of Risk (WISDOM): A Randomized Trial of Risk Assessment to Guide Breast Cancer Screening
Jeffrey Tice, MD | University of California, San Francisco

2:05 PM
Poster Talk 9

Alterations in Levels of Serum IGF-I and IGBFP-3 and Ultrasound Tomography Measures of Breast Density Following Tamoxifen Therapy
Gretchen Gierach, PhD | National Cancer Institute

2:25 PM
2:55 PM

Coffee Break

2:55 PM
3:55 PM

Risks Assessments II (cont.)

Moderator: Nico Karssemeijer
2:55 PM
Poster Talk 10

Statins and Metformin Use and Mammographic Breast Density
Erica Lee Argov | Mailman School of Public Health, Columbia University

3:35 PM
Plenary Talk 9

Combined screening with mammography and ultrasound in a population-based breast cancer screening program
Wolfgang Buchberger, MD, MSc | Institute of Quality and Efficiency in Medicine, UMIT

3:55 PM
4:25 PM

Panel Discussion and Questions